Brief: Anika Therapeutics Says Q2 Revenue Rose 1 Percent To $30.7 Million
30/07/2020 22:24
July 30 (Reuters) - Anika Therapeutics Inc ANIK.O :
* ANIKA REPORTS SECOND QUARTER 2020 FINANCIAL RESULTS
* Q2 LOSS PER SHARE $0.54
* Q2 REVENUE ROSE 1 PERCENT TO $30.7 MILLION
* Q2 ADJUSTED EARNINGS PER SHARE $0.09
* LAUNCHING SEVEN FDA-CLEARED ORTHOPEDIC AND SPORTS MEDICINE
PRODUCTS THROUGH Q3 2020
Source text for Eikon: ID:nGNX3147NX
Further company coverage: ANIK.O
((Reuters Messaging: Reuters.Briefs@thomsonreuters.com))